Google Alert - pharmaceutical news

News10 new results for pharmaceutical news Bristol-Myers to buy Amylin for about $5.3 blnMoneycontrol.comBristol-Myers Squibb Co will buy biotechnology company Amylin Pharmaceuticals Inc for about USD 5.3 billion in cash, helping Bristol-Myers extend its portfolio of diabetes treatments with the addition of drugs Byetta and Bydureon. Bristol-Myers said ...See all stories on this topic »Moneycontrol.comBristol-Myers to buy Amylin Pharmaceuticalsgulfnews.comNew York: Bristol-Myers Squibb Co agreed to pay $5.3 billion (Dh19.46 billion) to acquire Amylin Pharmaceuticals Inc, a maker of diabetes therapies, as it seeks to replace revenue from its top-selling blood thinner that's facing generic competition.See all stories on this topic »AstraZeneca...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news Ohr Pharmaceutical Announces $2.9 Million FinancingMarketWatch (press release)Dr. Irach B. Taraporewala, CEO of Ohr Pharmaceutical, added, "This financing will allow us to comfortably achieve several upcoming milestones in our Squalamine eye drop and OHR/AVR118 clinical programs in the remainder of 2012 and 2013. We would ...See all stories on this topic »Alembic Pharma named among co-defendants in Pfizer lawsuitMoneycontrol.comAlembic Pharmaceuticals and US-based Breckenridge Pharmaceutical have been named co-defendants in a Para IV lawsuit filed by Pfizer in relation to their abbreviated new drug application (ANDA) to market desvenlafaxine succinate extended-release ...See all stories on this...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news Arena's Diet Pill May Spur Renewed Race From DrugmakersBusinessweekArena Pharmaceuticals Inc. (ARNA)'s weight- loss pill, the first cleared in the U.S. in 13 years, and an expected rival are potential breakthroughs in the treatment of obesity that may spur major drugmakers into the market.See all stories on this topic »US regulator clears first new weight-loss pill in 13 yearsNDTVThe Food and Drug Administration has approved Arena Pharmaceutical's anti-obesity pill Belviq, the first new prescription drug for long-term weight loss to enter the U.S. market in over a decade. Despite only achieving modest weight loss in clinical ...See all stories on this topic »US agency approves first obesity drug...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news Pharma bigwigs including Abbott, Bayer, GlaxoSmithKline, Sanofi ...Economic TimesSeven pharmaceutical companies and four research institutions have teamed up with the Bill and Melinda Gates Foundation for the goal.See all stories on this topic »Tonix Pharmaceuticals to Present at LHA Life Sciences & Medical ...MarketWatch (press release)NEW YORK, Jun 27, 2012 (BUSINESS WIRE) -- Tonix Pharmaceuticals Holding Corp. (OBB:TNXP) ("TONIX" or the "Company"), which specializes in ...See all stories on this topic »Kedem Pharmaceuticals to Appoint New Chief Operating OfficerMarketWatch (press release)Dr. Maksumova joined Kedem Pharmaceuticals in 2011. She has brought over two decades of highly professional...

Read more »

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news Thomson Reuters Annual Pharmaceutical Factbook Reveals Key ...ReutersFewer projects with higher success rates show focus on quality paying off London, UK, 26 June 2012 - The In.See all stories on this topic »NPS Pharmaceuticals Launches Educational Website on ...MarketWatch (press release)NPS Pharmaceuticals is a biopharmaceutical company focused on bringing orphan products to patients with rare disorders and few, if any, therapeutic options.See all stories on this topic »European Pharmaceutical Leader Gedeon Richter Selects Psion ...MarketWatch (press release)"The business features of this rugged device make it the ideal tool for the pharmaceutical industry, offering workers access to robust and accurate information, ...See all stories on this...

Read more »

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news Natco Pharma loses patent case against Teva Pharmaceutical ...Economic TimesNatco Pharma has lost a patent litigation against Israel's Teva Pharmaceutical Industries in the US over multiple sclerosis treatment drug, Copaxone.See all stories on this topic »Natco, Mylan to appeal against New York district court verdictEconomic TimesThe decision by the US court covers several patents for the chemical composition of Copaxone, methods of using the product and processes for manufacturing ...See all stories on this topic »Synergy Pharmaceuticals Added to the Russell 3000(R), Russell ...MarketWatch (press release)NEW YORK, Jun 25, 2012 (GlobeNewswire via COMTEX) -- Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) (NASDAQ:SGYPU) (NASDAQ:SGYPW) , a ...See all...

Read more »

Google Alert - pharmaceutical news

News10 new results for pharmaceutical news Teva shares jump on positive Copaxone patent rulingMoneycontrol.comJERUSALEM (Reuters) - Teva Pharmaceutical Industries rose more than 11 percent on Sunday after a U.S. court upheld Teva's patents for multiple sclerosis ...See all stories on this topic »Moneycontrol.comTeva shares jump on positive Copaxone patent rulingIBNLive.comBy Steven Scheer JERUSALEM (Reuters) - Teva Pharmaceutical Industries rose more than 11 percent on Sunday after a U.S. court upheld Tevas patents for ...See all stories on this topic »Shengtai Pharmaceutical, Inc. Special Committee Selects Financial ...Business Review India (press release)WEIFANG, Shandong, China, June 23, 2012 /PRNewswire-Asia-FirstCall/ -- Shengtai...

Read more »